Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesSS-31 (Elamipretide) in 2026: Latest Clinical
A deep dive into SS-31 (Elamipretide)'s most recent clinical findings, focusing on 2025-2026 data and its implications for longevity and healthspan.
PeptidesCJC-1295: 2026’s Latest Evidence on Growth
Dive into the newest 2026 evidence surrounding CJC-1295 with DAC, examining its role in growth hormone modulation, clinical efficacy, and safety profile.
PeptidesCJC-1295: Latest 2026 Evidence and Revised
Dive into the cutting-edge research on CJC-1295, focusing on breakthroughs and revised recommendations emerging in 2026 for healthspan optimisation.
PeptidesRetatrutide: Latest 2026 Evidence and Revised
Retatrutide, the triple GIP/GLP-1/glucagon agonist, continues to reshape our understanding of metabolic intervention.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.